On the primary outcome, 31% of head tremor patients in the botulinum toxin group improved by at least 2 points on the Clinical Global Impression of Change (CGI) scale at 18 weeks, compared with 9% in ...

Please provide your email address to receive an email when new articles are posted on . Botulinum toxin has often been used to treat head tremor despite limited evidence of its use. The current study ...

Sept. 15, 2004 -- Botulinum toxin type A (BoNT-A) injections reduce voice tremor and speech disability in the absence of spasmodic dysphonia or head, mouth, jaw, or facial tremor, according to the ...

NORTH CHICAGO, Ill., Oct. 6, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA ...

Essential tremor is one of the most common movement disorders, yet it often is mistaken for other neurological conditions such as Parkinson’s disease. Affecting an estimated 7 to 10 million Americans, ...

For patients with isolated or essential head tremor, injection of botulinum toxin into each splenius capitis muscle on day 0 and during week 12 is more effective than placebo for reducing tremor ...

Injection of botulinum toxin into each splenius capitis muscle at baseline and week 12 was more effective than placebo in reducing the severity of essential head tremor over 18 weeks. Effects waned at ...

MINNEAPOLIS – Botulinum toxin may help prevent shaking or tremor in the arms and hands of people with multiple sclerosis (MS), according to new research published in the July 3, 2012, print issue of ...

Local injections of botulinum toxin are frequently used to treat head tremor, yet randomized trials assessing the effects have been limited. New research findings are summarized in a short video.